At a glance
ClinicalIndex Comparison RecordN/ACompleted· 62 enrolled
Drug / intervention
DBS of the STN +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cognition and Mood in Parkinson's Disease (PD) in Subthalamic Nucleus (STN) Versus Globus Pallidus Interna (GPi) Deep Brain Stimulation (DBS)
In Brief
A clinical study evaluating DBS of the STN and DBS of the GPI for Parkinson Disease. Completed, enrolled 62 participants across 1 site.
Detailed Summary
The purpose of this trial is to study the mood and cognitive effects of deep brain stimulation in Parkinson's disease.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson Disease
CountriesUnited States
Timeline
N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2004
First PostedAug 2006
Primary CompletionApr 2008
TodayJul 2026
First PostedAug 3, 2006
Enrollment StartJan 1, 2004
Primary CompletionApr 1, 2008
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 19.9 years ago
Interventions
DBS of the STNprocedure
Patients undergo Deep Brain Stimulation (DBS) of the subthalamic nucleus (STN) to treat Parkinson's Disease, using a Medtronic 3387 device.
DBS of the GPIprocedure
Patients undergo Deep Brain Stimulation (DBS) of the globus pallidus interna (Gpi) to treat Parkinson's disease, using a Medtronic 3387 device.